JPWO2022154116A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022154116A5
JPWO2022154116A5 JP2022575662A JP2022575662A JPWO2022154116A5 JP WO2022154116 A5 JPWO2022154116 A5 JP WO2022154116A5 JP 2022575662 A JP2022575662 A JP 2022575662A JP 2022575662 A JP2022575662 A JP 2022575662A JP WO2022154116 A5 JPWO2022154116 A5 JP WO2022154116A5
Authority
JP
Japan
Prior art keywords
group
affinity peptide
amino acid
linker
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022575662A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022154116A1 (https=
JP7687350B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/001358 external-priority patent/WO2022154116A1/ja
Publication of JPWO2022154116A1 publication Critical patent/JPWO2022154116A1/ja
Publication of JPWO2022154116A5 publication Critical patent/JPWO2022154116A5/ja
Priority to JP2025085873A priority Critical patent/JP2025124732A/ja
Application granted granted Critical
Publication of JP7687350B2 publication Critical patent/JP7687350B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022575662A 2021-01-18 2022-01-17 化合物またはその塩、およびそれらにより得られる抗体 Active JP7687350B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025085873A JP2025124732A (ja) 2021-01-18 2025-05-22 化合物またはその塩、およびそれらにより得られる抗体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021005762 2021-01-18
JP2021005762 2021-01-18
PCT/JP2022/001358 WO2022154116A1 (ja) 2021-01-18 2022-01-17 化合物またはその塩、およびそれらにより得られる抗体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025085873A Division JP2025124732A (ja) 2021-01-18 2025-05-22 化合物またはその塩、およびそれらにより得られる抗体

Publications (3)

Publication Number Publication Date
JPWO2022154116A1 JPWO2022154116A1 (https=) 2022-07-21
JPWO2022154116A5 true JPWO2022154116A5 (https=) 2025-01-27
JP7687350B2 JP7687350B2 (ja) 2025-06-03

Family

ID=82448186

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022575662A Active JP7687350B2 (ja) 2021-01-18 2022-01-17 化合物またはその塩、およびそれらにより得られる抗体
JP2025085873A Pending JP2025124732A (ja) 2021-01-18 2025-05-22 化合物またはその塩、およびそれらにより得られる抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025085873A Pending JP2025124732A (ja) 2021-01-18 2025-05-22 化合物またはその塩、およびそれらにより得られる抗体

Country Status (8)

Country Link
US (1) US20240000965A1 (https=)
EP (1) EP4279500A4 (https=)
JP (2) JP7687350B2 (https=)
KR (1) KR20230133294A (https=)
CN (1) CN116829573A (https=)
AU (1) AU2022208654B2 (https=)
CA (1) CA3208296A1 (https=)
WO (1) WO2022154116A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2020090979A1 (ja) * 2018-10-31 2021-09-24 味の素株式会社 抗体に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩
WO2023234416A1 (ja) 2022-06-02 2023-12-07 味の素株式会社 親和性物質、化合物、抗体およびそれらの塩

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106992A (en) 1988-02-11 1994-06-24 Bristol Myers Squibb Co Acylhydrazone derivatives of anthracycline and methods for their preparation
US5622929A (en) 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
US6214345B1 (en) 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
ATE234635T1 (de) 1995-12-22 2003-04-15 Bristol Myers Squibb Co Verzweigte hydrazongruppen enthaltende kuppler
EP1243276A1 (en) 2001-03-23 2002-09-25 Franciscus Marinus Hendrikus De Groot Elongated and multiple spacers containing activatible prodrugs
SI1545613T1 (sl) 2002-07-31 2011-11-30 Seattle Genetics Inc Avristatinski konjugati in njihova uporaba za zdravljenje raka avtoimunske bolezni ali infekcijskebolezni
JP2006507322A (ja) 2002-11-14 2006-03-02 シンタルガ・ビーブイ 多重自己脱離放出スペーサーとして構築されたプロドラッグ
US7498298B2 (en) 2003-11-06 2009-03-03 Seattle Genetics, Inc. Monomethylvaline compounds capable of conjugation to ligands
DE102004026304B3 (de) 2004-05-28 2005-08-25 Atlas Elektronik Gmbh Prüfverfahren für ein Verfahren zur passiven Gewinnung von Zielparamentern
JP5827769B1 (ja) 2015-03-27 2015-12-02 義徳 川窪 掃除装置
US10227383B2 (en) 2015-05-20 2019-03-12 Kagoshima University Specific modification of antibody with IgG-binding peptide
EP3617235B1 (en) 2017-04-28 2026-02-18 Ajinomoto Co., Inc. Compound having substance that has affinity for soluble protein, cleavable moiety, and reactive group, or salt thereof
CA3103143A1 (en) 2018-06-14 2019-12-19 Ajinomoto Co., Inc. Compound having affinity substance to antibody, cleavable portion, and reactive group, or salt thereof
CN112261954B (zh) 2018-06-14 2025-06-24 味之素株式会社 具有针对抗体的亲和性物质和生物正交性官能团的化合物或其盐
WO2020009165A1 (ja) 2018-07-03 2020-01-09 味の素株式会社 修飾抗体およびその製造方法
JP6581254B1 (ja) 2018-07-09 2019-09-25 セイコーソリューションズ株式会社 クロック調整装置及びプログラム
JP6677281B2 (ja) 2018-08-23 2020-04-08 ブラザー工業株式会社 インクジェット記録装置、及びプログラム
JPWO2020090979A1 (ja) 2018-10-31 2021-09-24 味の素株式会社 抗体に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩
JP7110955B2 (ja) 2018-12-04 2022-08-02 トヨタ自動車株式会社 インホイールモータ

Similar Documents

Publication Publication Date Title
JPWO2022154116A5 (https=)
JP2020513019A5 (https=)
JP2020519643A5 (https=)
JP2023052910A5 (https=)
RU2010116152A (ru) Антитело против рецептора il-6
JPWO2022191283A5 (https=)
AR040046A1 (es) Anticuerpo neutralizante humano anti-igfr
Kuby et al. Studies on adenosine triphosphate transphosphorylases. Amino acid sequence of rabbit muscle ATP-AMP transphosphorylase
RU2001119328A (ru) Применение металлоорганического соединения для защиты и/или усиления кератиновых материалов и способ обработки
JP2020506685A5 (https=)
JP2009529509A5 (https=)
JPWO2023234416A5 (https=)
CA2382035C (fr) Composes synthetiques portant deux epitopes pour immunodosages
Steiner et al. Crystallizable human myeloma protein Dob has a hinge-region deletion
JP2006503088A5 (https=)
Ottl et al. A new strategy for regioselective interstrand disulfide bridging of multiple cysteine peptides
Vesely et al. Production of monoclonal antibodies against immunoglobulin heavy chain in common carp (Cyprinus carpio L.)
Inman et al. Synthesis of N. alpha.-(tert-butoxycarbonyl)-N. epsilon.-[N-(bromoacetyl)-. beta.-alanyl]-L-lysine: Its use in peptide synthesis for placing a bromoacetyl cross-linking function at any desired sequence position
Wade et al. Use of thiazolidine-mediated ligation for site specific biotinylation of mouse EGF for biosensor immobilisation
AR125980A1 (es) Anticuerpos específicamente unidos a la proteína asm
CA2274303C (fr) Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i
Hanley et al. Distinct Ig H chains in a primitive vertebrate, Eptatretus stouti.
JP6583411B2 (ja) 薬物複合体
WO2002074962A1 (fr) Anticorps monoclonal reconnaissant l'acetyllysine et son procede de production
JP2021506272A (ja) 鎌状ベータグロビン抗体